Zoetis | ZTS - Selling And Administration Expenses

Stock Price
123.94
Daily Change
-0.88 -0.71%
Monthly
-4.20%
Yearly
-27.92%
Q1 Forecast
120.98

Zoetis reported $579M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
AbbVie USD 3.25B 40M Jun/2025
Align Technology USD 417.8M 30.89M Sep/2025
Bayer EUR 3.4B 140M Sep/2025
Bristol-Myers Squibb USD 1.79B 76M Sep/2025
Charles River Laboratories USD 177.59M 8.23M Sep/2025
Dentsply International USD 355M 21M Sep/2025
Eli Lilly USD 2.74B 12.3M Sep/2025
Henry Schein USD 760M 17M Sep/2025
Idexx Laboratories USD 265.09M 5.3M Sep/2025
Illumina USD 256M 59M Sep/2025
IQVIA Holdings USD 514M 5M Sep/2025
J&J USD 6.75B 831M Dec/2025
Laboratory Of America USD 552.4M 26.9M Sep/2025
Merck USD 2.63B 0 Sep/2025
Neogen USD 107.5M 1.56M Sep/2025
Pacira USD 91.8M 14.6M Sep/2025
Perrigo USD 245.7M 27.4M Sep/2025
Pfizer USD 3.19B 209M Sep/2025
Quest Diagnostics USD 501M 15M Sep/2025
Sanofi EUR 2.75B 455M Dec/2025
Sanofi EUR 2.75B 455M Dec/2025
Zoetis USD 579M 29M Sep/2025